Seeking Solutions for Large-Scale GMP Viral Vector Manufacturing: Innovation in manufacturing technologies must occur to ensure the availability of gene therapies and cell therapies.
| Publicado en: | Pharmaceutical Technology Vol. 43; no. 9; pp. 22 - 25 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Sep2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138564732&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 138564732 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15432521 4FK jtl: Pharmaceutical Technology issn: 15432521 maglogo: N pubinfo: dt: Sep2019 vid: 43 iid: 9 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 138564732 138564732 ppf: 22 ppct: 3 formats: fmt: @attributes: type: P tig: atl: Seeking Solutions for Large-Scale GMP Viral Vector Manufacturing: Innovation in manufacturing technologies must occur to ensure the availability of gene therapies and cell therapies. aug: au: Challener, Cynthia A. sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|